
New Delhi, 25 June 2020
Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.
Source -ndtv.com
If you like the story and if you wish more such stories, support our effort Make a donation.

Thu Apr 02 2026 | By Newsdesk

Thu Apr 02 2026 | By Newsdesk

Thu Apr 02 2026 | By Newsdesk

Thu Apr 02 2026 | By Newsdesk

Thu Apr 02 2026 | By Newsdesk